| |
| |
|
| Insider
Information: |
Mckinney Robert A |
| Relationship: |
Senior VP, CFO |
| City: |
Danbury |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
44,415 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$182,102 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
44,415 |
|
|
| Total
Value |
$182,102 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Progenics Pharmaceuticals Inc |
PGNX |
Senior VP, CFO |
2011-10-03 |
44,415 |
2003-07-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PGNX |
Progenics Pharmaceuticals... |
Senior VP, CFO |
• – – |
2011-10-03 |
4 |
D |
$5.44 |
$13,464 |
D/D |
(2,475) |
44,415 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Senior VP, CFO |
• – – |
2011-10-03 |
4 |
OE |
$4.62 |
$12,656 |
D/D |
2,737 |
46,890 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Senior VP, CFO |
• – – |
2011-07-01 |
4 |
D |
$7.40 |
$44,859 |
D/D |
(6,062) |
43,961 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Senior VP, CFO |
• – – |
2011-07-01 |
4 |
OE |
$5.46 |
$39,743 |
D/D |
7,279 |
50,023 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Senior VP, CFO |
• – – |
2011-06-17 |
4 |
AS |
$7.50 |
$22,500 |
D/D |
(3,000) |
42,444 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2011-04-01 |
4 |
OE |
$5.05 |
$12,600 |
D/D |
2,495 |
47,625 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2011-04-01 |
4 |
D |
$6.29 |
$13,718 |
D/D |
(2,181) |
45,444 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2011-01-03 |
4 |
D |
$5.68 |
$14,047 |
D/D |
(2,473) |
44,886 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2011-01-03 |
4 |
OE |
$4.83 |
$13,108 |
D/D |
2,715 |
47,359 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2010-10-01 |
4 |
OE |
$4.32 |
$35,533 |
D/D |
8,229 |
51,884 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2010-10-01 |
4 |
D |
$5.08 |
$37,805 |
D/D |
(7,442) |
44,442 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2010-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
43,437 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2010-07-01 |
4 |
D |
$5.35 |
$12,851 |
D/D |
(2,402) |
33,437 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2010-07-01 |
4 |
OE |
$4.44 |
$11,877 |
D/D |
2,675 |
35,839 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2010-06-18 |
4 |
AS |
$6.25 |
$25,000 |
D/D |
(4,000) |
32,925 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2010-01-04 |
4 |
OE |
$3.78 |
$11,905 |
D/D |
3,147 |
39,346 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2010-01-04 |
4 |
D |
$4.45 |
$12,745 |
D/D |
(2,864) |
36,482 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2009-10-01 |
4 |
D |
$5.01 |
$12,154 |
D/D |
(2,426) |
35,951 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2009-10-01 |
4 |
OE |
$4.26 |
$11,354 |
D/D |
2,666 |
38,377 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2009-06-19 |
4 |
AS |
$5.25 |
$26,265 |
D/D |
(5,000) |
34,590 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2009-04-01 |
4 |
D |
$6.65 |
$12,828 |
D/D |
(1,929) |
37,470 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2009-04-01 |
4 |
OE |
$5.65 |
$11,978 |
D/D |
2,120 |
39,590 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2009-01-02 |
4 |
D |
$10.74 |
$13,242 |
D/D |
(1,233) |
39,231 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2009-01-02 |
4 |
OE |
$9.13 |
$12,371 |
D/D |
1,355 |
40,464 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2008-10-01 |
4 |
D |
$13.93 |
$17,259 |
D/D |
(1,239) |
39,002 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
